Royalty and asset-light businesses lead the Canadian screen
DRI Healthcare Trust ranks first with a 59.80% trailing free-cash-flow margin. Diversified Royalty follows at 50.83%, while GoGold Resources and Conavi Medical also exceed 35%.
The leaders operate across pharmaceutical royalties, licensing, mining and medical technology. Their different business models mean the reported margins should be interpreted alongside the source, durability and reinvestment requirements of their cash flow.
Highest FCF margin
59.80%
DRI Healthcare Trust
Strongest five-year return
+1,006.3%
Amerigo Resources
Market-cap range
C$300M–C$2B
Canadian-listed companies
The 20-company free-cash-flow screen
Companies are ranked from highest to lowest trailing free-cash-flow-to-sales margin. Swipe or scroll horizontally to view every column.
YTD performance uses adjusted prices from December 31, 2025 to October 2, 2026. Five-year performance generally uses adjusted prices from September 30, 2021 to October 2, 2026. N/A indicates insufficient comparable trading history.
Regular dividend yield includes recurring dividends recorded during the trailing twelve months through October 2, 2026, divided by the October 2 adjusted closing price. Special and irregular distributions are excluded.
High cash conversion comes from several different economic models
DRI Healthcare Trust and Diversified Royalty receive royalty-linked cash flows, while GoGold, Amerigo, Meren Energy and Surge Energy are exposed to commodity prices, production levels and capital-spending cycles. Enghouse, Vitalhub and Computer Modelling Group rely more heavily on software, intellectual property and recurring customer relationships.
A similar free-cash-flow margin can therefore represent very different economics. Royalty income may require limited direct capital expenditure, whereas mining and energy cash flow can rise or fall sharply with commodity prices and development spending.
Strong share-price performance has not been universal
Amerigo Resources produced the strongest five-year return in the screen at more than 1,000%. Avino Silver & Gold Mines, Conavi Medical, Surge Energy and Vitalhub also recorded substantial long-term gains.
Other companies converted a meaningful percentage of revenue into cash while delivering weak share-price returns. Enghouse Systems, StorageVault, MTY Food Group and Altus Group demonstrate why cash conversion must be considered together with growth, valuation, balance-sheet risk and changes in investor expectations.
Commodity exposure drives much of the cyclicality
GoGold, Amerigo, Meren Energy, Surge Energy, Avino Silver & Gold Mines, Hemlo Mining and Trican Well Service are directly or indirectly influenced by commodity markets. Their trailing cash generation may benefit from favourable prices, production growth or temporarily restrained investment.
Investors should compare current cash flow with normalized commodity prices, reserve life, sustaining capital, development commitments and the company’s position within the industry cycle.
Regular dividends add an income dimension
Meren Energy has the highest regular trailing yield in the screen, followed by Enghouse Systems and Diversified Royalty. Surge Energy, MTY Food Group and Trican Well Service also return recurring cash to shareholders.
The calculation excludes identifiable special and irregular distributions. Even regular dividends can change, particularly for companies exposed to commodity prices, acquisitions, leverage or cyclical cash generation.
Cash-flow quality matters more than a single ranking
Free cash flow can be affected by working-capital movements, acquisition accounting, commodity prices, capitalized development, deferred investment and the timing of major projects. A high trailing margin should be reconciled with the cash-flow statement and compared across several reporting periods.
The strongest candidates are businesses capable of sustaining cash generation after necessary investment. Revenue growth, balance-sheet strength, competitive position and valuation remain essential parts of the analysis.